ING Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,374
| Closed | -$340K | – | 562 |
|
2022
Q2 | $340K | Buy |
+1,374
| New | +$340K | ﹤0.01% | 511 |
|
2022
Q1 | – | Sell |
-5,939
| Closed | -$2.13M | – | 624 |
|
2021
Q4 | $2.13M | Buy |
5,939
+2,129
| +56% | +$765K | 0.02% | 465 |
|
2021
Q3 | $1.24M | Buy |
3,810
+90
| +2% | +$29.3K | 0.02% | 471 |
|
2021
Q2 | $1.16M | Buy |
+3,720
| New | +$1.16M | 0.02% | 422 |
|
2021
Q1 | – | Sell |
-2,997
| Closed | -$972K | – | 564 |
|
2020
Q4 | $972K | Buy |
2,997
+2,000
| +201% | +$649K | 0.02% | 396 |
|
2020
Q3 | $276K | Buy |
+997
| New | +$276K | 0.01% | 413 |
|
2019
Q2 | – | Sell |
-6,715
| Closed | -$1.92M | – | 861 |
|
2019
Q1 | $1.92M | Buy |
6,715
+1,477
| +28% | +$422K | 0.04% | 219 |
|
2018
Q4 | $1.7M | Buy |
+5,238
| New | +$1.7M | 0.04% | 249 |
|
2018
Q3 | – | Sell |
-3,244
| Closed | -$1.33M | – | 884 |
|
2018
Q2 | $1.33M | Buy |
+3,244
| New | +$1.33M | 0.03% | 271 |
|
2017
Q4 | – | Sell |
-1,509
| Closed | -$254K | – | 920 |
|
2017
Q3 | $254K | Buy |
+1,509
| New | +$254K | ﹤0.01% | 749 |
|